XML 91 R81.htm IDEA: XBRL DOCUMENT v3.19.2
Other disclosures - Credit Risk - Movement in impairment allowance on loans and advances at amortised cost (Details) - GBP (£)
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost    
Credit impairment charges and other provisions £ 510,000,000 £ 156,000,000
Gross exposure [member] | Other financial assets subject to impairment [member]    
Loans and advances at amortised cost    
Opening balance 120,100,000,000  
Ending balance 159,900,000,000  
Impairment allowance [member]    
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost    
Credit impairment charges and other provisions 510,000,000  
Impairment allowance [member] | Loan commitments and financial guarantee contracts [member]    
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost    
Credit impairment charges and other provisions 22,000,000  
Impairment allowance [member] | Other financial assets subject to impairment [member]    
Loans and advances at amortised cost    
Opening balance 11,000,000  
Ending balance 21,000,000  
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost    
Credit impairment charges and other provisions [1] 6,000,000  
Financial assets at amortised cost [member] | Loans and advances [member]    
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost    
Decrease through write-off after applying recoveries, financial assets 580,000,000 745,000,000
Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member]    
Loans and advances at amortised cost    
Opening balance 140,802,000,000  
Business activity in the year 33,345,000,000  
Final repayments (24,037,000,000)  
Disposals (21,000,000)  
Write-offs (627,000,000) (788,000,000)
Ending balance 148,395,000,000  
Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 1 [member]    
Loans and advances at amortised cost    
Net transfers between stages 0  
Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 2 [member]    
Loans and advances at amortised cost    
Net transfers between stages 0  
Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 3 [member]    
Loans and advances at amortised cost    
Net transfers between stages 0  
Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member]    
Loans and advances at amortised cost    
Opening balance 3,843,000,000  
Business activity in the year 139,000,000  
Net re-measurement and movement due to exposure and risk parameter changes 521,000,000  
Final repayments (124,000,000)  
Disposals (21,000,000)  
Write-offs [2] (627,000,000)  
Ending balance [1] 3,731,000,000  
Reconciliation of ECL movement to impairment (charge)/release for the period, Loans and advances at amortised cost    
ECL movement excluding assets derecognised due to disposals and write-offs 536,000,000  
Post write-off recoveries 47,000,000 [2] £ 43,000,000
Exchange and other adjustments (7,000,000)  
Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 1 [member]    
Loans and advances at amortised cost    
Net transfers between stages 0  
Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 2 [member]    
Loans and advances at amortised cost    
Net transfers between stages 0  
Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 3 [member]    
Loans and advances at amortised cost    
Net transfers between stages 0  
Stage 1 [member] | Gross exposure [member] | Other financial assets subject to impairment [member]    
Loans and advances at amortised cost    
Opening balance 119,600,000,000  
Ending balance 159,400,000,000  
Stage 1 [member] | Impairment allowance [member] | Other financial assets subject to impairment [member]    
Loans and advances at amortised cost    
Opening balance 9,000,000  
Ending balance 13,000,000  
Stage 1 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member]    
Loans and advances at amortised cost    
Opening balance 122,589,000,000  
Business activity in the year 32,336,000,000  
Final repayments (21,819,000,000)  
Disposals 0  
Write-offs 0  
Ending balance 129,141,000,000  
Stage 1 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 1 [member]    
Loans and advances at amortised cost    
Net transfers between stages (4,661,000,000)  
Stage 1 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 2 [member]    
Loans and advances at amortised cost    
Net transfers between stages 3,540,000,000  
Stage 1 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 3 [member]    
Loans and advances at amortised cost    
Net transfers between stages 36,000,000  
Stage 1 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member]    
Loans and advances at amortised cost    
Opening balance 489,000,000  
Business activity in the year 95,000,000  
Net re-measurement and movement due to exposure and risk parameter changes (243,000,000)  
Final repayments (31,000,000)  
Disposals 0  
Write-offs 0  
Ending balance [1] 499,000,000  
Stage 1 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 1 [member]    
Loans and advances at amortised cost    
Net transfers between stages (58,000,000)  
Stage 1 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 2 [member]    
Loans and advances at amortised cost    
Net transfers between stages 246,000,000  
Stage 1 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 3 [member]    
Loans and advances at amortised cost    
Net transfers between stages 1,000,000  
Lifetime expected credit losses [member] | Stage 2 [member] | Gross exposure [member] | Financial assets at fair value through other comprehensive income [member]    
Loans and advances at amortised cost    
Opening balance 500,000,000  
Ending balance 500,000,000  
Lifetime expected credit losses [member] | Stage 2 [member] | Impairment allowance [member] | Financial assets at fair value through other comprehensive income [member]    
Loans and advances at amortised cost    
Opening balance 2,000,000  
Ending balance 3,000,000  
Lifetime expected credit losses [member] | Stage 2 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member]    
Loans and advances at amortised cost    
Opening balance 14,024,000,000  
Business activity in the year 984,000,000  
Final repayments (1,803,000,000)  
Disposals 0  
Write-offs 0  
Ending balance 14,878,000,000  
Lifetime expected credit losses [member] | Stage 2 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 1 [member]    
Loans and advances at amortised cost    
Net transfers between stages 4,348,000,000  
Lifetime expected credit losses [member] | Stage 2 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 2 [member]    
Loans and advances at amortised cost    
Net transfers between stages (4,255,000,000)  
Lifetime expected credit losses [member] | Stage 2 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 3 [member]    
Loans and advances at amortised cost    
Net transfers between stages 98,000,000  
Lifetime expected credit losses [member] | Stage 2 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member]    
Loans and advances at amortised cost    
Opening balance 1,255,000,000  
Business activity in the year 39,000,000  
Net re-measurement and movement due to exposure and risk parameter changes 251,000,000  
Final repayments (40,000,000)  
Disposals 0  
Write-offs [2] 0  
Ending balance [1] 1,107,000,000  
Lifetime expected credit losses [member] | Stage 2 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 1 [member]    
Loans and advances at amortised cost    
Net transfers between stages 51,000,000  
Lifetime expected credit losses [member] | Stage 2 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 2 [member]    
Loans and advances at amortised cost    
Net transfers between stages (456,000,000)  
Lifetime expected credit losses [member] | Stage 2 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 3 [member]    
Loans and advances at amortised cost    
Net transfers between stages 7,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Gross exposure [member] | Other financial assets subject to impairment [member]    
Loans and advances at amortised cost    
Opening balance 0  
Ending balance 5,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Impairment allowance [member] | Other financial assets subject to impairment [member]    
Loans and advances at amortised cost    
Opening balance 0  
Ending balance 5,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member]    
Loans and advances at amortised cost    
Opening balance 4,189,000,000  
Business activity in the year 25,000,000  
Final repayments (415,000,000)  
Disposals (21,000,000)  
Write-offs (627,000,000)  
Ending balance 4,376,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 1 [member]    
Loans and advances at amortised cost    
Net transfers between stages 313,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 2 [member]    
Loans and advances at amortised cost    
Net transfers between stages 715,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Financial assets at amortised cost [member] | Gross exposure [member] | Loans and advances [member] | Transfers from Stage 3 [member]    
Loans and advances at amortised cost    
Net transfers between stages (134,000,000)  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member]    
Loans and advances at amortised cost    
Opening balance 2,099,000,000  
Business activity in the year 5,000,000  
Net re-measurement and movement due to exposure and risk parameter changes 513,000,000  
Final repayments (53,000,000)  
Disposals (21,000,000)  
Write-offs [2] (627,000,000)  
Ending balance [1] 2,125,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 1 [member]    
Loans and advances at amortised cost    
Net transfers between stages 7,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 2 [member]    
Loans and advances at amortised cost    
Net transfers between stages 210,000,000  
Lifetime expected credit losses [member] | Credit Impaired - Stage 3 [member] | Financial assets at amortised cost [member] | Impairment allowance [member] | Loans and advances [member] | Transfers from Stage 3 [member]    
Loans and advances at amortised cost    
Net transfers between stages £ (8,000,000)  
[1]

Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income, accrued income and sundry debtors. These have a total gross exposure of £ 159.9 bn ( December 2018: £ 120.1 bn) and impairment allowance of £ 21 m ( December 2018: £ 11 m). This comprises £ 13 m ECL ( December 2018: £ 9 m) on £ 159.4 bn stage 1 assets ( December 2018: £ 119.6 bn) and £ 3 m ( December 2018: £ 2 m) on £ 0.5 bn stage 2 fa ir value through other comprehensive income assets ( December 2018: £ 0.5 bn) and £ 5 m ( December 2018: £ nil ) on £ 5 m Stage 3 other assets ( December 20 18: £ nil )

[2]

In H119 , gross write-offs amounted to £ 6 27 m ( H1 18: £ 788 m) and post write-off recoveries amounted to £ 47 m ( H1 18: £ 43 m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £ 5 80 m ( H1 18: £ 745 m)